Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Fda Inspections
  6. /
  7. Wyeth BioPharma Division of Wyeth Pharmaceuticals LLC
FDA Inspection
•Wyeth BioPharma Division of Wyeth Pharmaceuticals LLC•January 17, 2019

Wyeth BioPharma Division of Wyeth Pharmaceuticals LLC – FDA Inspection, Jan 17, 2019

Record Details

This FDA Inspection record concerns Wyeth BioPharma Division of Wyeth Pharmaceuticals LLC, with an inspection on January 17, 2019, issued by the New England District Office, covering human drugs.

Company
Wyeth BioPharma Division of Wyeth Pharmaceuticals LLC
Inspection Date
January 17, 2019
Product Type
Human Drugs
Office
New England District Office
People
  • Jee Y. Chung (Company Rep)
  • Sean R. Marcsisin (FDA Associated Person)
View Company Profile

ID · e986731a-745f-4e83-a2c3-c3e098bb7017

Inspection Facts

Voluntary Action Indicated (VAI)

Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.

Inspection number
1076789
FDA center
Human Drugs
Project area
Generic Drug Evaluation
Outcome
Form 483 issued

FDA Citations

2
  1. 21 CFR 211.160(a)Following/documenting laboratory controls
  2. 21 CFR 211.160(a)Lab controls established, including changes

Full citation text and observation details available on the Dashboard.

Other FDA inspections of Wyeth BioPharma Division of Wyeth Pharmaceuticals LLC

16
DateClassificationOfficeProject area
August 6, 2026Not classifiedNew England District Office
April 8, 2026Not classifiedNew England District Office
February 11, 2026NAIHuman Cellular, Tissue, and Gene Therapies
October 13, 2023NAICenter for Drug Evaluation and ResearchDrug Quality Assurance
September 19, 2023VAICenter for Biologics Evaluation and ResearchBlood and Blood Products
View all 16 other inspections on the company page
Other documents for Wyeth BioPharma Division of Wyeth Pharmaceuticals LLC
  • FDA Inspection 1331288 - 2026-08-06
  • FDA Inspection 1311392 - 2026-04-08
  • FDA Inspection 1304580 - 2026-02-11
  • FDA Inspection 1223617 - 2023-10-13
  • FDA Inspection 1218069 - 2023-09-19

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Wyeth BioPharma Division of Wyeth Pharmaceuticals LLC
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.